Skip to main content

Table 3 Comparative age-adjusted prevalence of health conditions in the FAHS and NHANES

From: Estimating the health consequences of flight attendant work: comparing flight attendant health to the general population in a cross-sectional study

Risk Factors and Health Outcomes

Gender

FAHS count, Unweighted

NHANES count, weighted

Prevalence FAHS, %

Prevalence NHANES, %

SPR (95% CI)

Overweight

Female

1306

768

29.7

59.7

0.50 (0.47–0.53)

 

Male

536

1048

44.7

72.6

0.62 (0.59–0.65)

Obesity

Female

304

441

7.1

34.3

0.21 (0.18–0.24)

 

Male

113

438

11.1

30.3

0.37 (0.33–0.41)

Current smoker

Female

295

208

7.2

16.1

0.44 (0.38–0.52)

 

Male

119

280

12.5

19.4

0.64 (0.56–0.74)

High cholesterol

Female

764

365

14.5

28.4

0.51 (0.46–0.57)

 

Male

262

470

18.8

32.6

0.58 (0.52–0.64)

Hypertension

Female

617

332

11.4

25.8

0.44 (0.39–0.50)

 

Male

237

384

16.6

26.6

0.63 (0.56–0.70)

Coronary heart disease

Female

42

16

0.67

1.3

0.53 (0.29–0.96)

 

Male

24

29

1.5

2.0

0.73 (0.47–1.15)

Chronic bronchitis

Female

239

72

4.6

5.6

0.82 (0.63–1.07)

 

Male

42

80

2.9

5.6

0.53 (0.40–0.70)

Asthma

Female

409

226

9.2

17.6

0.52 (0.45–0.61)

 

Male

83

191

7.0

13.3

0.53 (0.44–0.63)

Sleep disorder

Female

999

91

21.3

7.1

3.00 (2.45–3.69)

 

Male

225

128

17.5

8.9

1.98 (1.64–2.38)

Fatigue

Female

572

87

14.7

6.8

2.18 (1.75–2.70)

 

Male

123

61

12.8

4.2

3.04 (2.32–4.00)

Depression

Female

120

17

3.0

13.5

2.23 (1.36–3.66)

 

Male

50

13

5.1

0.9

5.57 (3.12–9.94)

Reproductive cancera

Female

267

38

4.9

2.9

1.66 (1.18–2.33)

Any cancerb

Female

771

86

14.3

6.7

2.15 (1.73–2.67)

 

Male

100

86

5.3

6

0.89 (0.69, 1.14)

  1. CI Confidence interval, FAHS Flight Attendant Health Study, NHANES National Health and Nutritional Examination Survey, SPR Standardized prevalence ratio
  2. aBreast, uterine, cervical, and ovarian cancers
  3. bBreast, ovarian, uterine, cervical, lung, oral, esophageal, prostate, testicular, colon, bladder, melanoma, non-melanoma skin, leukemia, thyroid, brain, lymphoma, liver, kidney, stomach and pancreatic cancers